Constraints on CD4 recovery postchemotherapy in adults

Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells

Frances T. Hakim, Rosemarie Cepeda, Song Kaimei, Crystal L. Mackall, Nanette McAtee, JoAnne Zujewski, Kenneth Cowan, Ronald E. Gress

Research output: Contribution to journalArticle

Abstract

To examine the mechanisms of CD4 reconstitution in an adult population, lymphocyte repopulation was assessed following dose-intense chemotherapy in 25 breast cancer patients, ages 33 to 69 years. Chemotherapy resulted in a greater than 60% reduction in total CD4 T cells and, in particular, a greater than 90% loss of the CD45RA+ CD4 cells. CD4 recovery was protracted, achieving less than 50% of pretreatment levels after 12 to 14 months. Two facets of the CD4 recovery were notable. First, generation of CD45RA+ CD4 cells played only a minor role in the first year, suggesting that thymic production was not the main route of CD4 regeneration. Indeed, recovery of CD45RA+ CD4 cell levels remained limited in half of the patients even after 2 years. Second, expansion of the mature peripheral CD4 cells (CD45RO+) remaining after chemotherapy was the main source of early CD4 repopulation, peaking at 3 to 6 months postchemotherapy. This expansion was limited in duration, however, and was followed by a secondary decline, such that the total CD45RO+ CD4 levels at 9 to 12 months were lower than at 6 months. When stimulated by mitogens, an increased susceptibility to apoptosis was observed in postchemotherapy CD4 cells as compared with those from normal donors. The elevated expression of markers such as HLA-DR during chemotherapy and for several months postchemotherapy is consistent with the presence of an activated T-cell population. CD4 apoptotic frequency correlated with the frequency of HLA-DR expression on T cells. Thus, CD4 recovery is constrained in adults by a limited thymic regenerative capacity and by an increased susceptibility to apoptosis within the expanding peripheral CD4 population.

Original languageEnglish (US)
Pages (from-to)3789-3798
Number of pages10
JournalBlood
Volume90
Issue number9
StatePublished - 1997
Externally publishedYes

Fingerprint

Chemotherapy
T-cells
Recovery
HLA-DR Antigens
Drug Therapy
T-Lymphocytes
Apoptosis
Lymphocytes
Population
Mitogens
Regeneration
Tissue Donors
Breast Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

Hakim, F. T., Cepeda, R., Kaimei, S., Mackall, C. L., McAtee, N., Zujewski, J., ... Gress, R. E. (1997). Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood, 90(9), 3789-3798.

Constraints on CD4 recovery postchemotherapy in adults : Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. / Hakim, Frances T.; Cepeda, Rosemarie; Kaimei, Song; Mackall, Crystal L.; McAtee, Nanette; Zujewski, JoAnne; Cowan, Kenneth; Gress, Ronald E.

In: Blood, Vol. 90, No. 9, 1997, p. 3789-3798.

Research output: Contribution to journalArticle

Hakim, FT, Cepeda, R, Kaimei, S, Mackall, CL, McAtee, N, Zujewski, J, Cowan, K & Gress, RE 1997, 'Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells', Blood, vol. 90, no. 9, pp. 3789-3798.
Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J et al. Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood. 1997;90(9):3789-3798.
Hakim, Frances T. ; Cepeda, Rosemarie ; Kaimei, Song ; Mackall, Crystal L. ; McAtee, Nanette ; Zujewski, JoAnne ; Cowan, Kenneth ; Gress, Ronald E. / Constraints on CD4 recovery postchemotherapy in adults : Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. In: Blood. 1997 ; Vol. 90, No. 9. pp. 3789-3798.
@article{5a79a59d54be48fbb0aa0bfeedca87b0,
title = "Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells",
abstract = "To examine the mechanisms of CD4 reconstitution in an adult population, lymphocyte repopulation was assessed following dose-intense chemotherapy in 25 breast cancer patients, ages 33 to 69 years. Chemotherapy resulted in a greater than 60{\%} reduction in total CD4 T cells and, in particular, a greater than 90{\%} loss of the CD45RA+ CD4 cells. CD4 recovery was protracted, achieving less than 50{\%} of pretreatment levels after 12 to 14 months. Two facets of the CD4 recovery were notable. First, generation of CD45RA+ CD4 cells played only a minor role in the first year, suggesting that thymic production was not the main route of CD4 regeneration. Indeed, recovery of CD45RA+ CD4 cell levels remained limited in half of the patients even after 2 years. Second, expansion of the mature peripheral CD4 cells (CD45RO+) remaining after chemotherapy was the main source of early CD4 repopulation, peaking at 3 to 6 months postchemotherapy. This expansion was limited in duration, however, and was followed by a secondary decline, such that the total CD45RO+ CD4 levels at 9 to 12 months were lower than at 6 months. When stimulated by mitogens, an increased susceptibility to apoptosis was observed in postchemotherapy CD4 cells as compared with those from normal donors. The elevated expression of markers such as HLA-DR during chemotherapy and for several months postchemotherapy is consistent with the presence of an activated T-cell population. CD4 apoptotic frequency correlated with the frequency of HLA-DR expression on T cells. Thus, CD4 recovery is constrained in adults by a limited thymic regenerative capacity and by an increased susceptibility to apoptosis within the expanding peripheral CD4 population.",
author = "Hakim, {Frances T.} and Rosemarie Cepeda and Song Kaimei and Mackall, {Crystal L.} and Nanette McAtee and JoAnne Zujewski and Kenneth Cowan and Gress, {Ronald E.}",
year = "1997",
language = "English (US)",
volume = "90",
pages = "3789--3798",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

TY - JOUR

T1 - Constraints on CD4 recovery postchemotherapy in adults

T2 - Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells

AU - Hakim, Frances T.

AU - Cepeda, Rosemarie

AU - Kaimei, Song

AU - Mackall, Crystal L.

AU - McAtee, Nanette

AU - Zujewski, JoAnne

AU - Cowan, Kenneth

AU - Gress, Ronald E.

PY - 1997

Y1 - 1997

N2 - To examine the mechanisms of CD4 reconstitution in an adult population, lymphocyte repopulation was assessed following dose-intense chemotherapy in 25 breast cancer patients, ages 33 to 69 years. Chemotherapy resulted in a greater than 60% reduction in total CD4 T cells and, in particular, a greater than 90% loss of the CD45RA+ CD4 cells. CD4 recovery was protracted, achieving less than 50% of pretreatment levels after 12 to 14 months. Two facets of the CD4 recovery were notable. First, generation of CD45RA+ CD4 cells played only a minor role in the first year, suggesting that thymic production was not the main route of CD4 regeneration. Indeed, recovery of CD45RA+ CD4 cell levels remained limited in half of the patients even after 2 years. Second, expansion of the mature peripheral CD4 cells (CD45RO+) remaining after chemotherapy was the main source of early CD4 repopulation, peaking at 3 to 6 months postchemotherapy. This expansion was limited in duration, however, and was followed by a secondary decline, such that the total CD45RO+ CD4 levels at 9 to 12 months were lower than at 6 months. When stimulated by mitogens, an increased susceptibility to apoptosis was observed in postchemotherapy CD4 cells as compared with those from normal donors. The elevated expression of markers such as HLA-DR during chemotherapy and for several months postchemotherapy is consistent with the presence of an activated T-cell population. CD4 apoptotic frequency correlated with the frequency of HLA-DR expression on T cells. Thus, CD4 recovery is constrained in adults by a limited thymic regenerative capacity and by an increased susceptibility to apoptosis within the expanding peripheral CD4 population.

AB - To examine the mechanisms of CD4 reconstitution in an adult population, lymphocyte repopulation was assessed following dose-intense chemotherapy in 25 breast cancer patients, ages 33 to 69 years. Chemotherapy resulted in a greater than 60% reduction in total CD4 T cells and, in particular, a greater than 90% loss of the CD45RA+ CD4 cells. CD4 recovery was protracted, achieving less than 50% of pretreatment levels after 12 to 14 months. Two facets of the CD4 recovery were notable. First, generation of CD45RA+ CD4 cells played only a minor role in the first year, suggesting that thymic production was not the main route of CD4 regeneration. Indeed, recovery of CD45RA+ CD4 cell levels remained limited in half of the patients even after 2 years. Second, expansion of the mature peripheral CD4 cells (CD45RO+) remaining after chemotherapy was the main source of early CD4 repopulation, peaking at 3 to 6 months postchemotherapy. This expansion was limited in duration, however, and was followed by a secondary decline, such that the total CD45RO+ CD4 levels at 9 to 12 months were lower than at 6 months. When stimulated by mitogens, an increased susceptibility to apoptosis was observed in postchemotherapy CD4 cells as compared with those from normal donors. The elevated expression of markers such as HLA-DR during chemotherapy and for several months postchemotherapy is consistent with the presence of an activated T-cell population. CD4 apoptotic frequency correlated with the frequency of HLA-DR expression on T cells. Thus, CD4 recovery is constrained in adults by a limited thymic regenerative capacity and by an increased susceptibility to apoptosis within the expanding peripheral CD4 population.

UR - http://www.scopus.com/inward/record.url?scp=0030833497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030833497&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 3789

EP - 3798

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -